TrialDiabetes care2013

Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.

Stephen C L Gough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.